$10.14-0.18|(-1.70%)

Analyst Recommendation Trends

Wall Street analyst consensus for ECOR over the last few months:

2026-09-01
Buy: 7
S.Buy: 3
Hold: 1
Sell: 0
2026-08-01
Buy: 7
S.Buy: 3
Hold: 1
Sell: 0
2026-07-01
Buy: 7
S.Buy: 3
Hold: 1
Sell: 0
2026-06-01
Buy: 7
S.Buy: 3
Hold: 1
Sell: 0

Latest ECOR News

electroCore Has A Line Of Sight At Cash Breakeven

electroCore shows improving financials and Quell growth, targeting 30%+ FY26 revenue. Click to read more about the Buy rating for ECOR.

SeekingAlpha9/26/2026

electroCore (ECOR) Stock Jumps 6.9%: Will It Continue to Soar?

electroCore (ECOR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Yahoo9/18/2026

Full Transcript: electroCore Q2 2026 Earnings Call

electroCore (NASDAQ:ECOR) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. This content is powered by Benzinga APIs. For

Benzinga9/18/2026

electroCore to Participate at H.C. Wainwright Global Investment Conference

ROCKAWAY, N.J., Sept. 10, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate in the H.C. Wainwright 28th Annual Global Investment Conference at the Lotte New York Palace Hotel. On Tuesday, September 15, 2026, Joshua Lev, Co-CEO, President and CFO, will participate in a fireside chat and host one-on-one meetings with investors during the conference. Investors who wish to reques

Yahoo9/10/2026

electroCore, Inc. Appoints Joshua Lev and Mike Fox as Co-Chief Executive Officers

Internal leadership appointments reflect the Company's confidence in two exceptional leaders whose complementary strengths will enhance shareholder valueROCKAWAY, N.J., Sept. 09, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company and leader in non-invasive vagus nerve stimulation technologies, today announced that it has appointed Joshua Lev and Mike Fox as Co-Chief Executive Officers and members of the Board of Directors, ef

Yahoo9/9/2026

electroCore Appoints Joshua Lev, Mike Fox As Co-CEOs, Effective Sept. 8

electroCore, Inc. (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness company and leader in non-invasive vagus nerve stimulation technologies, today announced that it has appointed Joshua Lev and Mike

Benzinga9/9/2026

Ecora Royalties PLC Announces Change of Registered Office Address

LONDON, UK / ACCESS Newswire / September 7, 2026 / Ecora (LSE:ECOR)(TSX:ECOR)(OTCQX:ECRAF), announces that its registered office has changed with immediate effect. The Company's new registered office address is: Carrington House 1st Floor West 126 - 130 Regent Street London W1B 5SEAll other Company contact details, including telephone numbers and website address, remain unchanged.

Yahoo9/7/2026

Ecora Royalties PLC Announces Investor Presentation via Engage Investor

LONDON, UK / ACCESS Newswire / September 3, 2026 / Ecora (LSE/TSX:ECOR)(OTCQX:ECRAF) is pleased to announce that the leadership team will host a live interactive presentation to discuss the recent 2026 Half Year Results on the Engage Investor platform, on Thursday 10th September 2026, at 2pm BST.Ecora welcomes all current shareholders and interested investors to join and encourages investors to pre-submit questions.

Yahoo9/3/2026

Related Stocks (Peers)

Companies operating in similar sectors to ECOR:

Recent Insider Transactions

DateNameShares ChangedPriceValue
2026-09-14Errico Thomas J.+5,000$9.8163$49,082
2026-09-11Fox Michael+5,000$9.8007$49,004
2026-09-11Fox Michael+5,000$9.8007$49,004
2026-09-09Theofilos James Charles+11,123--
2026-09-09Wilber Patricia+11,123--
2026-09-09Bonfiglioli Elena+11,123--
2026-09-09Goldstein Julie Ann+11,123--
2026-09-09Errico Thomas J.+15,572--
2026-09-09GANDOLFO JOHN P+11,123--
2026-09-08Fox Michael+55,000--
2026-09-08Lev Joshua S.+55,000--
2026-08-25Lev Joshua S.-3,000--
2026-08-25Lev Joshua S.-3,000$9.36$28,080
2026-08-25Lev Joshua S.+3,000$4.5$13,500
2026-08-24Lev Joshua S.-5,000--
2026-08-24Lev Joshua S.-5,000$9.88$49,400
2026-08-24Lev Joshua S.+5,000$4.5$22,500
2026-08-21Lev Joshua S.-12,000--
2026-08-21Lev Joshua S.-12,000$10.22$122,640
2026-08-21Lev Joshua S.+12,000$4.5$54,000
2026-08-13Errico Thomas J.+5,000$9.8544$49,272
2026-05-28Lev Joshua S.-6,667$9$60,003
2026-05-22Lev Joshua S.-3,000$6.5$19,500
2026-05-21Errico Thomas J.+9,992$5.99$59,852
2026-05-20Errico Thomas J.+8$5.98$48
2026-04-23Goldberger Daniel S-80,000$6.8$544,000
2026-04-13Fox Michael+70,000--
2026-04-10Goldberger Daniel S-16,072$6.02$96,753
2026-04-01Lev Joshua S.+45,000--
2026-03-19Errico Thomas J.+19,252--
2026-03-19Errico Thomas J.+22,803--
2026-03-19Errico Thomas J.+19,252$6.43$123,790
2026-03-19Errico Thomas J.+22,803$4.35$99,193
2026-01-26Lev Joshua S.+25,000--
2026-01-26Lev Joshua S.+2,889--
2026-01-26Goldberger Daniel S+26,000--
2026-01-26Goldberger Daniel S+20,375$7.47$152,201
2025-12-04Lev Joshua S.-2,500$5.05$12,625
2025-12-02Goldberger Daniel S+1,000$4.84$4,840
2025-11-12Lev Joshua S.-2,166$6.18$13,386